KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Free Cash Flow (2017 - 2025)

Historic Free Cash Flow for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to -$2.7 million.

  • Cardlytics' Free Cash Flow rose 2008.92% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.8 million, marking a year-over-year increase of 3068.64%. This contributed to the annual value of -$26.6 million for FY2024, which is 12300.59% down from last year.
  • Cardlytics' Free Cash Flow amounted to -$2.7 million in Q3 2025, which was up 2008.92% from -$3.1 million recorded in Q2 2025.
  • In the past 5 years, Cardlytics' Free Cash Flow registered a high of $3.0 million during Q2 2023, and its lowest value of -$22.0 million during Q1 2022.
  • For the 5-year period, Cardlytics' Free Cash Flow averaged around -$8.9 million, with its median value being -$10.4 million (2022).
  • In the last 5 years, Cardlytics' Free Cash Flow surged by 12858.24% in 2023 and then crashed by 200202.7% in 2025.
  • Cardlytics' Free Cash Flow (Quarter) stood at -$2.9 million in 2021, then plummeted by 446.45% to -$16.1 million in 2022, then skyrocketed by 96.96% to -$489000.0 in 2023, then tumbled by 172.8% to -$1.3 million in 2024, then crashed by 101.57% to -$2.7 million in 2025.
  • Its Free Cash Flow was -$2.7 million in Q3 2025, compared to -$3.1 million in Q2 2025 and -$10.7 million in Q1 2025.